Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis

BACKGROUND: Modification of splicing by chemotherapeutic drugs has usually been evaluated on a limited number of pre-mRNAs selected for their recognized or potential importance in cell proliferation or apoptosis. However, the pathways linking splicing alterations to the efficiency of cancer therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabriel, Maude, Delforge, Yves, Deward, Adeline, Habraken, Yvette, Hennuy, Benoit, Piette, Jacques, Klinck, Roscoe, Chabot, Benoit, Colige, Alain, Lambert, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399393/
https://www.ncbi.nlm.nih.gov/pubmed/25884497
http://dx.doi.org/10.1186/s12885-015-1259-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399393/
https://www.ncbi.nlm.nih.gov/pubmed/25884497
http://dx.doi.org/10.1186/s12885-015-1259-0

Ejemplares similares